The development of tuberculosis in patients receiving highly active anti-retroviral therapy for HIV infection

被引：0
|
作者：
Breen, RAM
Smith, CJ
Cropley, I
Johnson, MA
Lipman, MCI
机构：
[1] Royal Free Hosp, Dept Thorac Med, London NW3 2QG, England
[2] Royal Free Hosp, Dept HIV Med, London NW3 2QG, England
来源：
THORAX | 2004年 / 59卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART)
    Chiriboga, CA
    Fleishman, S
    Champion, S
    Gaye-Robinson, L
    Abrams, EJ
    JOURNAL OF PEDIATRICS, 2005, 146 (03): : 402 - 407
  • [2] Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
    Thomaidis, Loretta
    Bertou, Georgia
    Critselis, Elena
    Spoulou, Vassiliki
    Kafetzis, Dimitrios A.
    Theodoridou, Maria
    BMC PEDIATRICS, 2010, 10
  • [3] Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study
    Loretta Thomaidis
    Georgia Bertou
    Elena Critselis
    Vassiliki Spoulou
    Dimitrios A Kafetzis
    Maria Theodoridou
    BMC Pediatrics, 10
  • [4] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Mark E. Sharkey
    Ian Teo
    Thomas Greenough
    Natalia Sharova
    Katherine Luzuriaga
    John L. Sullivan
    R. Pat Bucy
    Leondios G. Kostrikis
    Ashley Haase
    Claire Veryard
    Raul E. Davaro
    Sarah H. Cheeseman
    Jennifer S. Daly
    Carol Bova
    Richard T. Ellison
    Brian Mady
    Kwan Kew Lai
    Graeme Moyle
    Mark Nelson
    Brian Gazzard
    Sunil Shaunak
    Mario Stevenson
    Nature Medicine, 2000, 6 : 76 - 81
  • [5] Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy
    Sharkey, ME
    Teo, I
    Greenough, T
    Sharova, N
    Luzuriaga, K
    Sullivan, JL
    Bucy, RP
    Kostrikis, LG
    Haase, A
    Veryard, C
    Davaro, RE
    Cheeseman, SH
    Daly, JS
    Bova, C
    Ellison, RT
    Mady, B
    Lai, KK
    Moyle, G
    Nelson, M
    Gazzard, B
    Shaunak, S
    Stevenson, M
    NATURE MEDICINE, 2000, 6 (01) : 76 - 81
  • [6] Improvement in Immunological Parameters in Patients Receiving Highly Active Anti-Retroviral Therapy in Nepal
    Tiwari, Bishnu Raj
    Karki, Surendra
    Ghimire, Prakash
    Sharma, Bimala
    Malla, Sarala
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (03) : 252 - 255
  • [7] Breast Discomfort in HIV Positive Patients Treated with Highly Active Anti-Retroviral Therapy
    Allan, E. G.
    Allan, P. S.
    DRUG SAFETY, 2014, 37 (10) : 846 - 847
  • [8] EFFICACY OF HIGHLY ACTIVE ANTI-RETROVIRAL THERAPY (HAART) IN PATIENTS WITH HBV-HIV CO-INFECTION
    Kosi, L.
    Reiberger, T.
    Rutter, K.
    pfistershammer, K.
    Rieger, A.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S143 - S143
  • [9] Progressive multifocal leukoencephalopathy treated with cidofovir in HIV-infected patients receiving highly active anti-retroviral therapy
    Portilla, J
    Boix, V
    Román, F
    Reus, S
    Merino, E
    JOURNAL OF INFECTION, 2000, 41 (02) : 182 - 184
  • [10] Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients
    de Olalla, PG
    Martínez-González, MA
    Caylà, JA
    Jansà, JM
    Iglesias, B
    Guerrero, R
    Marco, A
    Gatell, JM
    Ocaña, I
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (12) : 1051 - 1057
12345